• No results found

Hospital variation in combined liver resection and thermal ablation for colorectal liver metastases and impact on

In document Jeroen Bosch Ziekenhuis 2020 (pagina 37-44)

MEDISCHE MICROBIOLOGIE

K. Hospital variation in combined liver resection and thermal ablation for colorectal liver metastases and impact on

short-term postoperative outcomes: a nationwide population-based study. HPB (Oxford) 2020 November 17. PMID: 33218949.

Elfrink AKE, van Zwet EW, Swijnenburg RJ, den Dulk M, van den Boezem, P B, Mieog JSD, Te Riele WW, Patijn GA, Leclercq WKG, Lips DJ, Rijken AM, Verhoef C, Kuhlmann KFD, Buis CI, Bosscha* K, Belt EJT, Vermaas M, van Heek NT, Oosterling SJ, Torrenga H, Eker HH, Consten ECJ, Marsman HA, Wouters, M W J M, Kok NFM, Grunhagen DJ, Klaase JM, Dutch Hepato Biliary Audit Group. Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases. Eur J Surg Oncol 2020 October 16. PMID: 33183927

Gayet* MCW, van der Aa* AAMA, Beerlage HP, Schrier*

BP, Gielens* M, Heesakkers* R, Jager* GJ, Mulders PFA, Wijkstra H. Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI. Prostate Cancer 2020 April 03;2020:4626781. PMID: 32308996.

Groot HJ, van Leeuwen FE, Lubberts S, Horenblas S, de Wit R, Witjes JA, Groenewegen G, Poortmans PM, Hulshof, M C C M, Meijer OWM, de Jong IJ, van den Berg, H A, Smilde* TJ, Vanneste BGL, Aarts MJB, Jozwiak K, van den Belt-Dusebout, A W, Gietema JA, Schaapveld M. Platinum exposure and cause-specific mortality among patients with testicular cancer. Cancer 2020 February 01;126(3):628-639. PMID:

31730712.

F. LekCheck: A Prospective Study to Identify Perioperative Modifiable Risk Factors for Anastomotic Leakage in Colorectal Surgery. Ann Surg 2020 June 04. PMID: 32511133.

Issa* DE, Dinmohamed AG, Wondergem MJ, Blommestein HM, Huijgens PC, Lugtenburg PJ, Visser O, Zweegman S, Chamuleau MED. A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands. Leuk Lymphoma 2020 November 19:1-11. PMID: 33213245.

Klompmaker S, van Hilst J, Wellner UF, Busch OR, Coratti A, D’Hondt M, Dokmak S, Festen S, Kerem M, Khatkov I, Lips*

DJ, Lombardo C, Luyer M, Manzoni A, Molenaar IQ, Rosso E, Saint-Marc O, Vansteenkiste F, Wittel UA, Bonsing B, Groot Koerkamp B, Abu Hilal M, Fuks D, Poves I, Keck T, Boggi U, Besselink MG, European consortium on Minimally Invasive Pancreatic Surgery, (E-MIPS). Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy: A Pan-European Propensity Score Matched Study. Ann Surg 2020 February 01;271(2):356-363. PMID: 29864089.

Kuppen MCP, Westgeest HM, van den Eertwegh, A. J. M., Coenen, J. L. L. M., van Moorselaar, R. J. A., van den Berg P, Geenen MM, Mehra N, Hendriks MP, Lampe MI, van de Luijtgaarden, A. C. M., Peters FPJ, Roeleveld TA, Smilde*

TJ, de Wit R, van Oort IM, Gerritsen WR, Uyl-de Groot CA.

Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands. Clin Genitourin Cancer 2019 Dec 5. PMID: 31883940.

Kuppen MC, Westgeest HM, van der Doelen, M J, van den Eertwegh, A J, Coenen JL, Aben KK, van den Bergh, A C, Bergman AM, den Bosch JV, Celik F, Hendriks MP, Lavalaye J, der Meer* SV, Polee MB, Somford DM, van Oort IM, Uyl-de Groot CA, Gerritsen WR. Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer.

Future Oncol 2020 July 01;16(19):1371-1384. PMID:

32469606.

Latenstein AEJ, Mackay TM, van Huijgevoort, N C M, Bonsing BA, Bosscha* K, Hol L, Bruno MJ, van Coolsen, M M E, Festen S, van Geenen E, Groot Koerkamp B, Hemmink GJM, de Hingh, I H J T, Kazemier G, Lubbinge H, de Meijer VE, Molenaar IQ, Quispel R, van Santvoort HC, Seerden TCJ, Stommel MWJ, Venneman NG, Verdonk RC, Besselink MG, van Hooft JE, Dutch Pancreatic Cancer Group. Nationwide practice and outcomes of endoscopic biliary drainage in resectable pancreatic head and periampullary cancer. HPB (Oxford) 2020 July 16. PMID: 32682665.

Lugtenburg PJ, de Nully Brown P, van der Holt B, D’Amore FA, Koene HR, de Jongh E, Fijnheer R, van Esser JW, Bohmer LH, Pruijt* JF, Verhoef GE, Hoogendoorn M, Bilgin MY, Nijland M, van der Burg-de Graauw, N C, Oosterveld M, Jie KG, Larsen TS, van der Poel, M W, Leijs MB, Silbermann MH, van Marwijk Kooy M, Beker A, Kersten MJ, Doorduijn JK, Tick LW, Brouwer RE, Lam KH, Burggraaff CN, de Keizer B, Arens AI, de Jong D, Hoekstra OS, Zijlstra-Baalbergen JM. Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84). J Clin Oncol 2020 July 30:JCO1903418. PMID: 32730183.

Mackay TM, Smits FJ, Latenstein AEJ, Bogte A, Bonsing BA, Bos H, Bosscha* K, Brosens LAA, Hol L, Busch ORC, Creemers GJ, Curvers WL, den Dulk M, van Dieren S, van Driel, L M J W, Festen S, van Geenen, E J M, van der Geest, L G, de Groot, D J A, de Groot, J W B, Haj Mohammad N, Haberkorn BCM, Haver JT, van der Harst E, Hemmink GJM, de Hingh IH, Hoge C, Homs MYV, van Huijgevoort NC, Jacobs, M A J M, Kerver ED, Liem MSL, Los M, Lubbinge H, Luelmo SAC, de Meijer VE, Mekenkamp L, Molenaar IQ, van Oijen, M G H, Patijn GA, Quispel R, van Rijssen LB, Romkens* TEH, van Santvoort HC, Schreinemakers JMJ, Schut* H, Seerden T, Stommel MWJ, Ten Tije AJ, Venneman NG, Verdonk RC, Verheij J, van Vilsteren, F G I, de Vos-Geelen J, Vulink A, Wientjes C, Wit F, Wessels FJ, Zonderhuis B, van Werkhoven CH, van Hooft JE, van Eijck, C H J, Wilmink JW, van Laarhoven, H W M, Besselink MG, Dutch Pancreatic Cancer Group. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial. Trials 2020 April 16;21(1):334-z. PMID: 32299515.

Mackay TM, Smits FJ, Roos D, Bonsing BA, Bosscha* K, Busch OR, Creemers GJ, van Dam RM, van Eijck, C H J, Gerhards MF, de Groot, J W B, Groot Koerkamp B, Haj Mohammad N, van der Harst E, de Hingh, I H J T, Homs MYV, Kazemier G, Liem MSL, de Meijer VE, Molenaar IQ, Nieuwenhuijs VB, van Santvoort HC, van der Schelling, G P, Stommel MWJ, Ten Tije AJ, de Vos-Geelen J, Wit F, Wilmink JW, van Laarhoven, H W M, Besselink MG, Dutch Pancreatic Cancer Group. The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis. HPB (Oxford) 2020 February 01;22(2):233-240. PMID: 31439478.

Nielsen LK, Stege C, Lissenberg-Witte B, van der Holt B, Mellqvist UH, Salomo M, Bos G, Levin MD, Visser-Wisselaar H, Hansson M, van der Velden A, Deenik W, Coenen J, Hinge M, Klein S, Tanis B, Szatkowski D, Brouwer R, Westerman M, Leys R, Sinnige* H, Haukas E, van der Hem K, Durian M, Gimsing P, van de Donk N, Sonneveld P, Waage A, Abildgaard N, Zweegman S. Health-related quality of life in transplant

ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study. Haematologica 2020 June 01;105(6):1650-1659. PMID: 31515355.

Olthof PB, Elfrink AKE, Marra E, Belt EJT, van den Boezem, P B, Bosscha* K, Consten ECJ, den Dulk M, Gobardhan PD, Hagendoorn J, van Heek, T N T, IJzermans JNM, Klaase JM, Kuhlmann KFD, Leclercq WKG, Liem MSL, Manusama ER, Marsman HA, Mieog JSD, Oosterling SJ, Patijn GA, Te Riele W, Swijnenburg RJ, Torrenga H, van Duijvendijk P, Vermaas M, Kok NFM, Grunhagen DJ, Dutch Hepato Biliary Audit Group.

Volume-outcome relationship of liver surgery: a nationwide analysis. Br J Surg 2020 June 01;107(7):917-926. PMID:

32207856.

Otero-Pineiro AM, de Lacy FB, Van Laarhoven* JJ, Martin-Perez B, Valverde S, Bravo R, Lacy AM. The impact of fluorescence angiography on anastomotic leak rate following transanal total mesorectal excision for rectal cancer: a comparative study. Surg Endosc 2020 February 18. PMID:

32072284.

Postema AW, Gayet* MCW, van Sloun, R J G, Wildeboer RR, Mannaerts CK, Savci-Heijink CD, Schalk SG, Kajtazovic* A, van der Poel H, Mulders PFA, Beerlage HP, Mischi M, Wijkstra H. Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimens. World J Urol 2020 February 20.

PMID: 32078707.

Pouwels, X G L V, Geurts SME, Ramaekers BLT, Erdkamp F, Vriens, B E P J, Aaldering KNA, van de Wouw, A J, Dercksen MW, Smilde* TJ, Peters, N A J B, Riel JMV, Pepels MJ, Heijnen-Mommers J, Joore MA, Tjan-Heijnen VCG, de Boer M. The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry. Acta Oncol 2020 January 01;59(1):82-89. PMID: 31583931.

Pouwels, X G L V, Ramaekers BLT, Geurts SME, Erdkamp F, Vriens, B E P J, Aaldering KNA, van de Wouw, A J, Dercksen MW, Smilde* TJ, Peters, N A J B, van Riel, J M G H, Pepels MJ, Heijnen-Mommers J, Tjan-Heijnen VCG, de Boer M, Joore MA. An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry. Acta Oncol 2020 June

16:1-population-based cohort study. Cancer Treat Res Commun 2020;25:100266. PMID: 33316557.

Rojo F, Corassa M, Mavroudis D, Oz AB, Biesma* B, Brcic L, Pauwels P, Sailer V, Gosney J, Miljkovic D, Hader C, Wu M, Almarez T, Penault-Llorca F. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer 2020 July 27;147:237-243. PMID: 32745892.

Schraa SJ, van Rooijen KL, van der Kruijssen, D E W, Rubio Alarcon C, Phallen J, Sausen M, Simmons J, Coupe VMH, van Grevenstein, W M U, Elias S, Verkooijen HM, Lacle MM, Bosch LJW, van den Broek D, Meijer GA, Velculescu VE, Fijneman RJA, Vink GR, Koopman M, PLCRC-MEDOCC group (Jeroen Bosch Ziekenhuis). Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE):

study protocol for a trial within a cohort study. BMC Cancer 2020 August 20;20(1):790-y. PMID: 32819390.

Smits FJ, Henry AC, van Eijck CH, Besselink MG, Busch OR, Arntz M, Bollen TL, van Delden OM, van den Heuvel D, van der Leij C, van Lienden KP, Moelker A, Bonsing BA, Borel Rinkes, I H M, Bosscha* K, van Dam RM, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IH, Kazemier G, Liem M, van der Kolk, B M, de Meijer VE, Patijn GA, Roos D, Schreinemakers JM, Wit F, van Werkhoven CH, Molenaar IQ, van Santvoort HC, Dutch Pancreatic Cancer Group. Care after pancreatic resection according to an algorithm for early detection and minimally invasive management of pancreatic fistula versus current practice (PORSCH-trial): design and rationale of a nationwide stepped-wedge cluster-randomized trial. Trials 2020 May 07;21(1):389-9. PMID: 32381031.

Sparreboom CL, Komen N, Rizopoulos D, Verhaar AP, Dik WA, Wu Z, van Westreenen HL, Doornebosch PG, Dekker JWT, Menon AG, Daams F, Lips* D, van Grevenstein, W M U, Karsten TM, Bayon Y, Peppelenbosch MP, Wolthuis AM, D’Hoore A, Lange JF. A multicentre cohort study of serum and peritoneal biomarkers to predict anastomotic leakage after rectal cancer resection. Colorectal Dis 2020 January 01;22(1):36-45. PMID: 31344302.

van den Broek D, Hiltermann TJN, Biesma* B, Dinjens WNM, ‘t Hart NA, Hinrichs JWJ, Leers MPG, Monkhorst K, van Oosterhout M, Scharnhorst V, Schuuring E, Speel EM, van den Heuvel, M M, van Schaik, R H N, von der Thusen J, Willems SM, de Visser L, Ligtenberg MJL. Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.

Brekel, M W M, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek, W T, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse, L V, Verdonck-de Leeuw IM. The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? Acta Oncol 2020 December 21:1-9. PMID: 33345659.

van der Hout A, Jansen F, van Uden-Kraan CF, Coupe VM, Holtmaat K, Nieuwenhuijzen GA, Hardillo JA, de Jong, R J B, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha* K, van den Brekel, M W M, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek, W T, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse, L V, Verdonck-de Leeuw IM. Cost-utility of an eHealth application ‘Oncokompas’ that supports cancer survivors in self-management: results of a randomised controlled trial. J Cancer Surviv 2020 July 12. PMID: 32656739.

van der Hout A, van Uden-Kraan CF, Holtmaat K, Jansen F, Lissenberg-Witte BI, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong, R J, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RE, Bosscha* K, van den Brekel, M W M, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek, W T, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse, L V, Verdonck-de Leeuw IM. Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol 2020 January 01;21(1):80-94. PMID: 31838009.

van der Linden* RLA, Rijstenberg LL, van der Linden*, J C, Vogelaar FJ, Nagtegaal ID, Pruijt* JFM, van de Velde, C J H, van den Brule* A, Bosscha* K. Node negative colorectal cancer patients: assesment of high-risk features on recurrence. Pathol Res Pract 2020 September 01;216(9):153034. PMID: 32825973.

van de Ven, S E M, Backes Y, Hilbink* M, Seerden TCJ, Kessels K, de Vos Tot Nederveen Cappel, W H, Groen JN, Wolfhagen FHJ, Geesing JMJ, Borg FT, van Bergeijk J, Spanier BWM, Mundt MW, Pullens HJM, Boonstra JJ, Opsteeg B, van Lent, A U G, Schrauwen RWM, Lacle MM, Moons LMG, Terhaar Sive Droste* JS, Dutch T1 CRC Working Group.

Periprocedural adverse events after endoscopic resection of T1 colorectal carcinomas. Gastrointest Endosc 2020 January 01;91(1):142-152.e3. PMID: 31525362.

van de Ven, S E M, Derikx, L A A P, Nagtegaal ID, van Herpen CM, Takes RP, Melchers WJG, Pierik M, van den Heuvel T, Verhoeven RHA, Hoentjen F, Nissen* LHC. Laryngeal

Carcinoma in Patients With Inflammatory Bowel Disease:

Clinical Outcomes and Risk Factors. Inflamm Bowel Dis 2020 June 18;26(7):1060-1067. PMID: 31559415.

van Roessel S, Mackay TM, van Dieren S, van der Schelling, G P, Nieuwenhuijs VB, Bosscha* K, van der Harst E, van Dam RM, Liem MSL, Festen S, Stommel MWJ, Roos D, Wit F, Molenaar IQ, de Meijer VE, Kazemier G, de Hingh, I H J T, van Santvoort HC, Bonsing BA, Busch OR, Groot Koerkamp B, Besselink MG, Dutch Pancreatic Cancer Group. Textbook Outcome: Nationwide Analysis of a Novel Quality Measure in Pancreatic Surgery. Ann Surg 2020 January 01;271(1):155-162. PMID: 31274651.

van Veggel* B, Madeira R Santos, J F V, Hashemi SMS, Paats MS, Monkhorst K, Heideman DAM, Groves M, Radonic T, Smit EF, Schuuring E, van der Wekken, A J, de Langen AJ. Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer. Lung Cancer 2020 March 01;141:9-13. PMID: 31926441.

Veld JV, Amelung* FJ, Borstlap WAA, van Halsema EE, Consten* ECJ, Dekker JWT, Siersema PD, Ter Borg F, van der Zaag, E S, Fockens P, Bemelman WA, de Wilt, J H W, van Hooft JE, Tanis PJ, Dutch Snapshot Research Group.

Decompressing Stoma a s Bridge to Elective Surgery is an Effective Strategy for Left-sided Obstructive Colon Cancer: A National, Propensity-score Matched Study. Ann Surg 2020 November 01;272(5):738-743. PMID: 32833768.

Veld JV, Kumcu A, Amelung* FJ, Borstlap WAA, Consten ECJ, Dekker JWT, van Westreenen HL, Siersema PD, Ter Borg F, Kusters M, Bemelman WA, de Wilt, J H W, van Hooft JE, Tanis PJ, Dutch Snapshot Research Group. Time interval between self-expandable metal stent placement or creation of a decompressing stoma and elective resection of left-sided obstructive colon cancer. Endoscopy 2020 December 18.

PMID: 33339059.

Veld J, Umans D, van Halsema E, Amelung* F, Fernandes D, Lee MS, Stupart D, Suarez J, Tomiki Y, Bemelman W, Fockens P, Consten E, Tanis P, van Hooft J. Self-expandable metal stent (SEMS) placement or emergency surgery as palliative treatment for obstructive colorectal cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2020 September 22;155:103110. PMID: 33038693.

Vermeulen BD, Bruggeman L, Bac DJ, Schrauwen RWM, Epping LSM, Scheffer* RCH, Tan, A C I T L, Groenen MJM, Verhoeven RHA, Siersema PD. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a

population-based study. Acta Oncol 2020 April 01;59(4):410-416. PMID: 32067535.

Versteijne E, Suker M, Groen JV, Besselink MG, Bonsing BA, Bosscha* K, Busch OR, de Hingh, I H J T, De Jong KP, Molenaar IQ, van Santvoort HC, Verkooijen HM, Van Eijck CH, van Tienhoven G, Dutch Pancreatic Cancer Group. External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer:

Outcome of Eligible But Non-Randomized Patients. Ann Surg 2020 December 02. PMID: 33273349.

Wensink GE, Elferink MAG, May AM, Mol L, Hamers PAH, Bakker SD, Creemers GJ, de Groot, J W B, de Klerk GJ, Haberkorn BCM, Haringhuizen AW, Hoekstra R, Hunting JCB, Kerver ED, Mathijssen-van Stein D, Polee MB, Pruijt*

JFM, Quarles van Ufford-Mannesse P, Radema S, Rietbroek RC, Simkens LHJ, Tanis BC, Ten Bokkel Huinink D, Tjin-A-Ton MLR, Tromp-van Driel CS, Troost MM, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk MA, van Dodewaard-de Jong, J M, van Druten EB, van Voorthuizen T, Jan Veldhuis G, Verheul HMW, Vestjens, H J H M J, Vincent J, Kranenburg OW, Punt CJA, Vink GR, Roodhart JML, Koopman M. Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era. Br J Cancer 2020 October 13.

PMID: 33046804.

Westerdijk K, Krens SD, van der Graaf, W T A, Mulder SF, van Herpen, C M L, Smilde* T, van Erp NP, Desar IME. The relationship between sunitinib exposure and both efficacy and toxicity in real-world patients with renal cell carcinoma and gastrointestinal stromal tumour. Br J Clin Pharmacol 2020 May 01. PMID: 32358810.

Zwager LW, Bastiaansen BAJ, Bronzwaer MES, van der Spek, B W, Heine GDN, Haasnoot KJC, van der Sluis H, Perk LE, Boonstra JJ, Rietdijk ST, Wolters HJ, Weusten, B L A M, Gilissen LPL, Ten Hove WR, Nagengast WB, Bekkering FC, Schwartz MP, Terhaar Sive Droste* JS, Vlug MS, Houben, M H M G, Rando Munoz FJ, Seerden TCJ, Beaumont H, de Ridder R, Dekker E, Fockens P, Dutch eFTR Group. Endoscopic full-thickness resection (eFTR) of colorectal lesions: results from the Dutch colorectal eFTR registry. Endoscopy 2020 June 04. PMID: 32498100.

Willemsen M. Optimizing everolimus treatment in advanced breast cancer patients. Radboud University Medical Center Nijmegen; 2020. (copromotor: Tol* J).

Proefschrift

Dingemans SA, Birnie MFN, Sanders FRK, van den Bekerom, M P J, Backes M, van Beeck E, Bloemers FW, van Dijkman B, Flikweert E, Haverkamp D, Holtslag HR, Hoogendoorn JM, Joosse P, Parkkinen M, Roukema G, Sosef N, Twigt BA, van Veen RN, van der Veen, A H, Vermeulen J, Winkelhagen J, van der Zwaard*, B C, van Dieren S, Goslings JC, Schepers T. Correction to: Routine versus on demand removal of the syndesmotic screw; a protocol for an international randomised controlled trial (RODEO-trial). BMC Musculoskelet Disord 2020 August 05;21(1):520-7. PMID: 32758205.

Lehr AM, Delawi D, van Susante, J L C, Verschoor* N, Wolterbeek N, Oner FC, Kruyt MC. Long-term (> 10 years) clinical outcomes of instrumented posterolateral fusion for spondylolisthesis. Eur Spine J 2020 December 03. PMID:

33269455.

Louwerens JKG, Hockers N, Achten G, Sierevelt IN, Nolte PA, van Hove* RP. No clinical difference between TiN-coated versus unTiN-coated cementless CoCrMo mobile-bearing total knee arthroplasty; 10-year follow-up of a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2020 May 04. PMID: 32367201.

van der Zwaard* BC, Roerdink* RL, Van Hove* RP.

Increase in early wound leakage in total knee arthroplasty with local infiltrative analgesia (LIA) that includes epinephrine:

a retrospective cohort study. Acta Orthop 2020 September 08:1-5. PMID: 32896193.

van der Zwaard* BC, Stein* CE, Bootsma* JEM, van Geffen* HJAA, Douw* CM, Keijser*s CJPW. Correction to: Fewer patients undergo surgery when adding a comprehensive geriatric assessment in older patients with a hip fracture. Arch Orthop Trauma Surg 2020 April 01;140(4):493-6. PMID: 31784836.

van der Zwaard* BC, Stein* CE, Bootsma* JEM, van Geffen* HJAA, Douw* CM, Keijsers* CJPW. Fewer patients undergo surgery when adding a comprehensive geriatric assessment in older patients with a hip fracture. Arch Orthop Trauma Surg 2020 April 01;140(4):487-492. PMID:

31664575.

Vissers* LCM, van Hove* RP, van der Zwaard* BC.

Predicting self-reported functional improvement one year after primary total knee arthroplasty using pre- and postoperative patient-reported outcome measures. Knee 2020 June 01;27(3):683-689. PMID: 32563423.

ORTHOPEDIE

Wetenschappelijke publicaties

19

Balkenhol MCA, Vreuls W, Wauters CAP, Mol* SJJ, van der Laak, J A W M, Bult P. Histological subtypes in triple negative breast cancer are associated with specific information on survival. Ann Diagn Pathol 2020 June 01;46:151490. PMID:

32179443.

Loonen* AJM, Huijsmans* CJJ, Geurts-Giele WRR, Leeijen* C, van der Linden* JC, van den Brule* AJ C. Performance analysis of high-throughput HPV testing on three automated workflows. APMIS 2020 August 01;128(8):497-505. PMID: 32562292.

Loopik DL, Melchers WJ, Vedder JE, van den Brule* AJ, Massuger LF, Bekkers RL, Siebers AG. Authors’ reply re:

Reflex cytology for triage of high-risk human-papillomavirus-positive self-sampled material in cervical cancer screening:

a prospective cohort study. BJOG 2020 August 31. PMID:

32864828.

Loopik DL, Melchers W, Vedder J, van den Brule* A, Massuger L, Bekkers R, Siebers AG. Reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: a prospective cohort study. BJOG 2020 June 07. PMID: 32506627.

Moonen L, Derks JL, Hermans BCM, Bunnik IM, Hillen LM, van Suylen* RJ, den Bakker MA, von der Thusen, J H, Damhuis RA, van den Broek, E C, Buikhuisen WA, Dingemans

Ter Avest* MM, van Hee* K, Bronkhorst* C, de Jonge*

HJM. Mesalazine induced autoimmune hepatitis in a patient with Crohn’s disease. Clin Res Hepatol Gastroenterol 2020 November 03. PMID: 33158802.

van den Brand M, Nooijen* PTGA, van der Laan, K D, de Bruin PC, van Leeuwen* AMG, Leeuwis JW, Meijer JW, Otte-Holler I, Hebeda KM. Discrepancies in digital hematopathology diagnoses for consultation and expert panel analysis.

Virchows Arch 2020 August 25. PMID: 32840673.

van der Linden*, R L A, Rijstenberg LL, van der Linden*, J C, Vogelaar FJ, Nagtegaal ID, Pruijt* JFM, van de Velde, C J H, van den Brule* A, Bosscha* K. Node negative colorectal cancer patients: assesment of high-risk features on recurrence. Pathol Res Pract 2020 September 01;216(9):153034. PMID: 32825973.

Voeten* LM, Koopmans* MJ, Weppner-Parren* LJMT.

Cutaneous presentation of a bladder carcinoma mimicking an epidermal cyst. Int J Dermatol 2020 December 15. PMID:

Cutaneous presentation of a bladder carcinoma mimicking an epidermal cyst. Int J Dermatol 2020 December 15. PMID:

In document Jeroen Bosch Ziekenhuis 2020 (pagina 37-44)